Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Assets (2016 - 2026)

Iradimed has reported Current Assets over the past 14 years, most recently at $86.4 million for Q1 2026.

  • Quarterly Current Assets rose 15.02% to $86.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $86.4 million through Mar 2026, up 15.02% year-over-year, with the annual reading at $81.2 million for FY2025, 7.92% up from the prior year.
  • Current Assets was $86.4 million for Q1 2026 at Iradimed, up from $81.2 million in the prior quarter.
  • Over five years, Current Assets peaked at $86.4 million in Q1 2026 and troughed at $61.3 million in Q1 2023.
  • The 5-year median for Current Assets is $74.3 million (2024), against an average of $74.0 million.
  • Year-over-year, Current Assets decreased 6.44% in 2023 and then increased 17.27% in 2024.
  • A 5-year view of Current Assets shows it stood at $77.5 million in 2022, then decreased by 1.92% to $76.0 million in 2023, then fell by 1.0% to $75.2 million in 2024, then grew by 7.92% to $81.2 million in 2025, then grew by 6.43% to $86.4 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Current Assets are $86.4 million (Q1 2026), $81.2 million (Q4 2025), and $84.9 million (Q3 2025).